Keyword → DHR

Earnings Season Accelerates: Tesla, Boeing, UnitedHealth, Intel, GE Aerospace and 80+ S&P 500 Companies Report This Week

The Q1 2026 earnings season enters its most consequential stretch this week, with more than 88 S&P 500 companies reporting, headlined by Tesla on Wednesday, Boeing Tuesday, UnitedHealth Group and GE Aerospace Tuesday, and Intel on Monday after the close. Analysts expect 12.6% aggregate S&P 500 EPS growth — what would be a sixth consecutive quarter of double-digit earnings expansion — though forward guidance on energy costs and margin trajectories will command more investor attention than headline beats.

ADP Report: Private Payrolls Rise 63,000 in February, Beating Estimates but Revealing Narrow Job Growth

The ADP National Employment Report released Wednesday showed U.S. private employers added 63,000 jobs in February, topping consensus estimates of 50,000 and improving from a downwardly revised 11,000 in January. However, gains were concentrated almost entirely in construction and education and health services, with professional and business services shedding 30,000 positions, raising questions about underlying labor market breadth ahead of Friday's official nonfarm payrolls report.

ISM Manufacturing PMI Holds at 52.4% in February, But Input Price Surge Raises Fed Rate-Cut Doubts

The Institute for Supply Management reported that U.S. manufacturing activity expanded for the second consecutive month in February, with the PMI reading at 52.4 percent, but the report's input prices sub-index soared at its fastest pace since 2022, reinforcing investor concerns that renewed inflationary pressures — now compounded by surging oil prices from the Iran conflict — could lead the Federal Reserve to delay or abandon interest rate cuts in the months ahead.

U.S. Business Activity Growth Slows Significantly in February, Signals Economic Softening

New data from S&P Global shows that U.S. business activity expanded at the slowest pace in nearly a year in February, reflecting reduced manufacturing orders and slower services growth. While the economy remains in expansion territory, the slowdown could weigh on sentiment and corporate investment plans if the trend persists, particularly in cyclical sectors tied to industrial production and hiring.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.